Dr Alain Reinhardt’s Post

Good health is an asset that can create enormous benefits for people, societies, economies and the planet. It is critical that health is viewed as a strategic long-term investment that helps economic growth and environmental sustainability. AstraZeneca is proud to be contributing towards this goal by: 🤝Mobilising partners within and beyond our sector to improve health outcomes while reducing the environmental and economic burden of care, with collaborations such as the Partnership for Health System Sustainability and Resilience.  ⏳ Supporting a transition towards a model of care that focuses on screening, early detection and treatment.  🧬Harnessing our cutting-edge scientific innovations to deliver next generation mechanisms and modalities of treatment where needed, within specialist care pathways. These themes and more were raised by Michel Demaré, Chair of the Board AstraZeneca, in his article in ‘Health: a Political Choice - Building Resilience and Trust’. He stresses that the magnitude of the challenge demands a collaborative approach, combined with sustained and strategic investment. Read the article here:

Good health is an asset that can create enormous benefits for people, societies, economies and the planet. It is critical that health is viewed as a strategic long-term investment that helps economic growth and environmental sustainability. AstraZeneca is proud to be contributing towards this goal by: 🤝Mobilising partners within and beyond our sector to improve health outcomes while reducing the environmental and economic burden of care, with collaborations such as the Partnership for Health System Sustainability and Resilience.  ⏳ Supporting a transition towards a model of care that focuses on screening, early detection and treatment.  🧬Harnessing our cutting-edge scientific innovations to deliver next generation mechanisms and modalities of treatment where needed, within specialist care pathways. These themes and more were raised by Michel Demaré, Chair of the Board AstraZeneca, in his article in ‘Health: a Political Choice - Building Resilience and Trust’. He stresses that the magnitude of the challenge demands a collaborative approach, combined with sustained and strategic investment. Read the article here:

Good health is an asset that can create enormous benefits for people, societies, economies and the planet. It is critical that health is viewed as a strategic long-term investment that helps economic growth and environmental sustainability. AstraZeneca is proud to be contributing towards this goal by: 🤝Mobilising partners within and beyond our sector to improve health outcomes while reducing the environmental and economic burden of care, with collaborations such as the Partnership for Health System Sustainability and Resilience.  ⏳ Supporting a transition towards a model of care that focuses on screening, early detection and treatment.  🧬Harnessing our cutting-edge scientific innovations to deliver next generation mechanisms and modalities of treatment where needed, within specialist care pathways. These themes and more were raised by Michel Demaré, Chair of the Board AstraZeneca, in his article in ‘Health: a Political Choice - Building Resilience and Trust’. He stresses that the magnitude of the challenge demands a collaborative approach, combined with sustained and strategic investment. Read the article here:

Good health is an asset that can create enormous benefits for people, societies, economies and the planet. It is critical that health is viewed as a strategic long-term investment that helps economic growth and environmental sustainability. AstraZeneca is proud to be contributing towards this goal by: 🤝Mobilising partners within and beyond our sector to improve health outcomes while reducing the environmental and economic burden of care, with collaborations such as the Partnership for Health System Sustainability and Resilience.  ⏳ Supporting a transition towards a model of care that focuses on screening, early detection and treatment.  🧬Harnessing our cutting-edge scientific innovations to deliver next generation mechanisms and modalities of treatment where needed, within specialist care pathways. These themes and more were raised by Michel Demaré, Chair of the Board AstraZeneca, in his article in ‘Health: a Political Choice - Building Resilience and Trust’. He stresses that the magnitude of the challenge demands a collaborative approach, combined with sustained and strategic investment. Read the article here:

Good health is an asset that can create enormous benefits for people, societies, economies and the planet. It is critical that health is viewed as a strategic long-term investment that helps economic growth and environmental sustainability. AstraZeneca is proud to be contributing towards this goal by: 🤝Mobilising partners within and beyond our sector to improve health outcomes while reducing the environmental and economic burden of care, with collaborations such as the Partnership for Health System Sustainability and Resilience.  ⏳ Supporting a transition towards a model of care that focuses on screening, early detection and treatment.  🧬Harnessing our cutting-edge scientific innovations to deliver next generation mechanisms and modalities of treatment where needed, within specialist care pathways. These themes and more were raised by Michel Demaré, Chair of the Board AstraZeneca, in his article in ‘Health: a Political Choice - Building Resilience and Trust’. He stresses that the magnitude of the challenge demands a collaborative approach, combined with sustained and strategic investment. Read the article here:

Good health is an asset that can create enormous benefits for people, societies, economies and the planet. It is critical that health is viewed as a strategic long-term investment that helps economic growth and environmental sustainability. AstraZeneca is proud to be contributing towards this goal by: 🤝Mobilising partners within and beyond our sector to improve health outcomes while reducing the environmental and economic burden of care, with collaborations such as the Partnership for Health System Sustainability and Resilience.  ⏳ Supporting a transition towards a model of care that focuses on screening, early detection and treatment.  🧬Harnessing our cutting-edge scientific innovations to deliver next generation mechanisms and modalities of treatment where needed, within specialist care pathways. These themes and more were raised by Michel Demaré, Chair of the Board AstraZeneca, in his article in ‘Health: a Political Choice - Building Resilience and Trust’. He stresses that the magnitude of the challenge demands a collaborative approach, combined with sustained and strategic investment. Read the article here:

Good health is an asset that can create enormous benefits for people, societies, economies and the planet. It is critical that health is viewed as a strategic long-term investment that helps economic growth and environmental sustainability. AstraZeneca is proud to be contributing towards this goal by: 🤝Mobilising partners within and beyond our sector to improve health outcomes while reducing the environmental and economic burden of care, with collaborations such as the Partnership for Health System Sustainability and Resilience.  ⏳ Supporting a transition towards a model of care that focuses on screening, early detection and treatment.  🧬Harnessing our cutting-edge scientific innovations to deliver next generation mechanisms and modalities of treatment where needed, within specialist care pathways. These themes and more were raised by Michel Demaré, Chair of the Board AstraZeneca, in his article in ‘Health: a Political Choice - Building Resilience and Trust’. He stresses that the magnitude of the challenge demands a collaborative approach, combined with sustained and strategic investment. Read the article here:

Good health is an asset that can create enormous benefits for people, societies, economies and the planet. It is critical that health is viewed as a strategic long-term investment that helps economic growth and environmental sustainability. AstraZeneca is proud to be contributing towards this goal by: 🤝Mobilising partners within and beyond our sector to improve health outcomes while reducing the environmental and economic burden of care, with collaborations such as the Partnership for Health System Sustainability and Resilience.  ⏳ Supporting a transition towards a model of care that focuses on screening, early detection and treatment.  🧬Harnessing our cutting-edge scientific innovations to deliver next generation mechanisms and modalities of treatment where needed, within specialist care pathways. These themes and more were raised by Michel Demaré, Chair of the Board AstraZeneca, in his article in ‘Health: a Political Choice - Building Resilience and Trust’. He stresses that the magnitude of the challenge demands a collaborative approach, combined with sustained and strategic investment. Read the article here:

Good health is an asset that can create enormous benefits for people, societies, economies and the planet. It is critical that health is viewed as a strategic long-term investment that helps economic growth and environmental sustainability. AstraZeneca is proud to be contributing towards this goal by: 🤝Mobilising partners within and beyond our sector to improve health outcomes while reducing the environmental and economic burden of care, with collaborations such as the Partnership for Health System Sustainability and Resilience.  ⏳ Supporting a transition towards a model of care that focuses on screening, early detection and treatment.  🧬Harnessing our cutting-edge scientific innovations to deliver next generation mechanisms and modalities of treatment where needed, within specialist care pathways. These themes and more were raised by Michel Demaré, Chair of the Board AstraZeneca, in his article in ‘Health: a Political Choice - Building Resilience and Trust’. He stresses that the magnitude of the challenge demands a collaborative approach, combined with sustained and strategic investment. Read the article here:

Good health is an asset that can create enormous benefits for people, societies, economies and the planet. It is critical that health is viewed as a strategic long-term investment that helps economic growth and environmental sustainability. AstraZeneca is proud to be contributing towards this goal by: 🤝Mobilising partners within and beyond our sector to improve health outcomes while reducing the environmental and economic burden of care, with collaborations such as the Partnership for Health System Sustainability and Resilience.  ⏳ Supporting a transition towards a model of care that focuses on screening, early detection and treatment.  🧬Harnessing our cutting-edge scientific innovations to deliver next generation mechanisms and modalities of treatment where needed, within specialist care pathways. These themes and more were raised by Michel Demaré, Chair of the Board AstraZeneca, in his article in ‘Health: a Political Choice - Building Resilience and Trust’. He stresses that the magnitude of the challenge demands a collaborative approach, combined with sustained and strategic investment. Read the article here: